In a recent paper researchers from Massachusetts Eye and Ear/Harvard Medical School Department of Ophthalmology, Boston Children’s Hospital, and the Massachusetts Institute of Technology explained how they developed a "drug-eluting contact lens designed for prolonged delivery of latanoprost for the treatment of glaucoma".